Literature DB >> 20156957

Principles for defining adverse events in behavioral intervention research: lessons from a family-focused adolescent drug abuse trial.

Viviana E Horigian1, Michael S Robbins, Roberto Dominguez, Jessica Ucha, Carmen L Rosa.   

Abstract

BACKGROUND: Behavioral intervention research has lagged behind biomedical research in developing principles for defining, categorizing, identifying, reporting, and monitoring adverse events and unanticipated problems.
PURPOSE: In this article we present a set of principles for defining adverse events and how they were applied in a large national multi-site family therapy study for substance-using adolescents, The Brief Strategic Family Therapy (BSFT) Effectiveness Study.
METHODS: The BSFT Effectiveness study tested how BSFT compares to Treatment as Usual (TAU) for the treatment of drug-abusing adolescents. During protocol development, experts in the BSFT intervention, medical safety officers, ethicists and senior investigators defined the procedures for identifying, tracking and reporting adverse events for drug using adolescents as well as their family members. During this process the team identified five key guiding principles.
RESULTS: The five guiding principles that were used for defining adverse events in this behavioral trial were that that the adverse events should be validated and plausible, and that monitoring systems should assess relatedness, be systematic, and are a shared responsibility. The following non-serious adverse events were identified: arrest, school suspension and drop out, runaway, kicked out of home and violence. The serious adverse events in this study for the identified adolescent participant and all other consented family members were physical or sexual abuse, suicidal behavior, homicidal behavior, hospitalization (drug related or psychiatric related only) and death. The methods used in categorizing, identifying and reporting adverse events in the BSFT trial are outlined. More than 50% of the adolescent population (277/481 = 57.5 %) experienced an adverse event during the trial. Family members experienced less adverse events, (61/1338 = 4.5%). The most common event for the adolescent group was arrest (164/277= 59.2%), followed by school suspension/dropout (143/277 = 51.6%), and runaway (79/277= 28.5 %). For the family member group, the most common event was violence (25/ 61 = 40.9%) followed by arrest (13/61 = 21.3%). There was a significant difference in the presence of adverse events in family members that were randomized to BSFT 44/721 (6.1%) when compared to Treatment as Usual 17/617 (2.8%) (p = 0.004). A probable explanation for this is that there were more opportunities to identify adverse events for family members assigned to BSFT because family members attended therapy sessions. This difference may also represent the risk for family members that participate in an evidence-based family intervention like BSFT. LIMITATIONS: The utility of the principles outside of the BSFT trial is unknown.
CONCLUSIONS: Based on the events reported in this trial, the efforts for monitoring and categorizing adverse events appeared justified and appropriate. The strategies and principles described in this paper may be useful for those developing safety plans for behavioral intervention research, and to family therapy researchers for assessing the safety of behavioral family interventions.

Entities:  

Mesh:

Year:  2010        PMID: 20156957      PMCID: PMC3163837          DOI: 10.1177/1740774509356575

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  23 in total

1.  Multisystemic treatment of substance-abusing and dependent delinquents: outcomes, treatment fidelity, and transportability.

Authors:  S W Henggeler; S G Pickrel; M J Brondino
Journal:  Ment Health Serv Res       Date:  1999-09

2.  Developmental associations between substance use and violence.

Authors:  H R White; R Loeber; M Stouthamer-Loeber; D P Farrington
Journal:  Dev Psychopathol       Date:  1999

Review 3.  Improving safety reporting from randomised trials.

Authors:  John P A Ioannidis; Joseph Lau
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 4.  Iatrogenic effects of alcohol and drug prevention programs.

Authors:  Chudley E Werch; Deborah M Owen
Journal:  J Stud Alcohol       Date:  2002-09

5.  Toward protecting the safety of participants in clinical trials.

Authors:  Robert M Califf; Michael A Morse; Janet Wittes; Steven N Goodman; Daniel K Nelson; David L DeMets; R Peter Iafrate; Jeremy Sugarman
Journal:  Control Clin Trials       Date:  2003-06

6.  Safety reporting in randomized trials of mental health interventions.

Authors:  Panagiotis N Papanikolaou; Rachel Churchill; Kristian Wahlbeck; John P A Ioannidis
Journal:  Am J Psychiatry       Date:  2004-09       Impact factor: 18.112

7.  Monitoring and ensuring safety during clinical research.

Authors:  M A Morse; R M Califf; J Sugarman
Journal:  JAMA       Date:  2001-03-07       Impact factor: 56.272

8.  Multidimensional family therapy for adolescent drug abuse: results of a randomized clinical trial.

Authors:  H A Liddle; G A Dakof; K Parker; G S Diamond; K Barrett; M Tejeda
Journal:  Am J Drug Alcohol Abuse       Date:  2001-11       Impact factor: 3.829

9.  Four-year follow-up of multisystemic therapy with substance-abusing and substance-dependent juvenile offenders.

Authors:  Scott W Henggeler; W Glenn Clingempeel; Michael J Brondino; Susan G Pickrel
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2002-07       Impact factor: 8.829

10.  Brief strategic family therapy for adolescent drug abusers: a multi-site effectiveness study.

Authors:  Michael S Robbins; José Szapocznik; Viviana E Horigian; Daniel J Feaster; Marc Puccinelli; Petra Jacobs; Kathy Burlew; Robert Werstlein; Ken Bachrach; Greg Brigham
Journal:  Contemp Clin Trials       Date:  2009-01-18       Impact factor: 2.226

View more
  14 in total

1.  Human subjects protection: an event monitoring committee for research studies of girls from breast cancer families.

Authors:  Diana Harris; Linda Patrick-Miller; Lisa Schwartz; John Lantos; Chris Daugherty; Mary Daly; Irene L Andrulis; Saundra S Buys; Wendy K Chung; Caren J Frost; Esther M John; Theresa H M Keegan; Julia A Knight; Mary Beth Terry; Angela R Bradbury
Journal:  J Adolesc Health       Date:  2014-05-17       Impact factor: 5.012

2.  Definition, assessment and rate of psychotherapy side effects.

Authors:  Michael Linden; Marie-Luise Schermuly-Haupt
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

3.  Defining and measuring meditation-related adverse effects in mindfulness-based programs.

Authors:  Willoughby B Britton; Jared R Lindahl; David J Cooper; Nicholas K Canby; Roman Palitsky
Journal:  Clin Psychol Sci       Date:  2021-11-01

4.  Mortality Rates Among Substance Use Disorder Participants in Clinical Trials: Pooled Analysis of Twenty-Two Clinical Trials Within the National Drug Abuse Treatment Clinical Trials Network.

Authors:  Robert Lindblad; Lian Hu; Neal Oden; Paul Wakim; Carmen Rosa; Paul VanVeldhuisen
Journal:  J Subst Abuse Treat       Date:  2016-08-15

5.  Clinical and Cost-Effectiveness of PSYCHOnlineTHERAPY: Study Protocol of a Multicenter Blended Outpatient Psychotherapy Cluster Randomized Controlled Trial for Patients With Depressive and Anxiety Disorders.

Authors:  Harald Baumeister; Natalie Bauereiss; Anna-Carlotta Zarski; Lina Braun; Claudia Buntrock; Christian Hoherz; Abdul Rahman Idrees; Robin Kraft; Pauline Meyer; Tran Bao Dat Nguyen; Rüdiger Pryss; Manfred Reichert; Theresa Sextl; Maria Steinhoff; Lena Stenzel; Lena Steubl; Yannik Terhorst; Ingrid Titzler; David Daniel Ebert
Journal:  Front Psychiatry       Date:  2021-05-14       Impact factor: 4.157

6.  Protocol for the Feasibility, Acceptability, and Preliminary Efficacy Trial of text4FATHER for Improving Underserved Fathers' Involvement in Infant Care.

Authors:  Arik V Marcell; Sara B Johnson; Tim Nelson; Alain B Labrique; Kathryn Van Eck; Sara Skelton; Anushka Aqil; Dustin Gibson
Journal:  J Health Care Poor Underserved       Date:  2021

Review 7.  The recording of adverse events from psychological treatments in clinical trials: evidence from a review of NIHR-funded trials.

Authors:  Conor Duggan; Glenys Parry; Mary McMurran; Kate Davidson; Jane Dennis
Journal:  Trials       Date:  2014-08-27       Impact factor: 2.279

8.  Effectiveness and cost-effectiveness of a guided internet- and mobile-based depression intervention for individuals with chronic back pain: protocol of a multi-centre randomised controlled trial.

Authors:  Jiaxi Lin; Lasse Sander; Sarah Paganini; Sandra Schlicker; David Ebert; Matthias Berking; Jürgen Bengel; Stephanie Nobis; Dirk Lehr; Oskar Mittag; Heleen Riper; Harald Baumeister
Journal:  BMJ Open       Date:  2017-12-28       Impact factor: 2.692

9.  Culturally Relevant Family Therapy Practice with Parents of Children and Adolescents.

Authors:  Tania Roy; A Thirumoorthy; R Parthasarathy
Journal:  Indian J Psychol Med       Date:  2017 Mar-Apr

10.  Monitoring adverse social and medical events in public health trials: assessing predictors and interpretation against a proposed model of adverse event reporting.

Authors:  Gwenllian Moody; Katy Addison; Rebecca Cannings-John; Julia Sanders; Carolyn Wallace; Michael Robling
Journal:  Trials       Date:  2019-12-30       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.